TABLE 2-1Measles Control versus Elimination strategies

Routine Immunization1 dose
≥ 90% coverage
2 doses
≥ 95% coverage
Supplementary ImmunizationHigh-risk areas
9 months to 5 years
Broad age range
SurveillanceIntegrate with AFP
Aggregate case counts
Virus isolation
Lab confirmation

From: 2, Major Efforts for Disease Eradication

Cover of Considerations for Viral Disease Eradication
Considerations for Viral Disease Eradication: Lessons Learned and Future Strategies: Workshop Summary.
Institute of Medicine (US) Forum on Emerging Infections; Knobler S, Lederberg J, Pray LA, editors.
Washington (DC): National Academies Press (US); 2002.
Copyright © 2002, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.